NASDAQ: VSEEVsee Health Inc Stock
$0.70-0.02 (-2.78%)
Updated Sep 12, 2025
VSEE Price
$0.70
Fair Value Price
N/A
Market Cap
$11.45M
52 Week Low
$0.58
52 Week High
$3.54
P/E
-0.12x
P/B
-619.14x
P/S
1.33x
PEG
N/A
Dividend Yield
N/A
Revenue
$10.42M
Earnings
-$57.70M
Gross Margin
68.9%
Operating Margin
-567.43%
Profit Margin
-553.7%
Debt to Equity
-1,082.38
Operating Cash Flow
-$6M
Beta
0.32
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
VSEE Overview
Digital Health Acquisition Corp. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets technology and healthcare-focused businesses. Digital Health Acquisition was incorporated in 2021 and is based in Boca Raton, FL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine VSEE's potential to beat the market
- VSEE doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
VSEE
RankedUnranked of 43
RankedUnranked of 43
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $20.09 | A | |
| $17.48 | A | |
| $17.33 | B |
Be the first to know about important VSEE news, forecast changes, insider trades & much more!
VSEE News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how VSEE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
VSEE is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
VSEE is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
VSEE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more VSEE due diligence checks available for Premium users.
Valuation
VSEE fair value
Fair Value of VSEE stock based on Discounted Cash Flow (DCF)
Price
$0.70
Fair Value
-$0.25
Undervalued by
382.09%
VSEE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
VSEE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.12x
Industry
82.65x
Market
36.98x
VSEE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-619.14x
Industry
4.11x
VSEE's financial health
Profit margin
Revenue
$3.9M
Net Income
-$5.6M
Profit Margin
-145.6%
VSEE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
VSEE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$20.0M
Liabilities
$20.0M
Debt to equity
-1,082.38
VSEE's short-term liabilities ($19.01M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VSEE's short-term assets ($3.02M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VSEE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
VSEE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.0M
Investing
-$4.8k
Financing
$977.8k
VSEE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
VSEE vs Health Information Service Stocks
Vsee Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.